Chengdu Syncor Pharmaceutical Co., Ltd.
Clinical trials sponsored by Chengdu Syncor Pharmaceutical Co., Ltd., explained in plain language.
-
New hope for bone metastases: experimental drug targets advanced tumors
Disease control Not yet recruitingThis study tests an experimental drug called BPR-6023021 in people with advanced solid tumors that have spread to the bones. The goal is to see if the drug is safe and can help control the cancer. About 195 adults who have tried other treatments or have no standard options will t…
Phase: PHASE1, PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New combo therapy aims to end recurring vaginal infections
Prevention Not yet recruitingThis study tests whether taking BPR-101 capsules along with standard antibiotic treatment can prevent bacterial vaginosis (BV) from returning. About 80 women with BV will receive either the study drug or a placebo. The goal is to see if the combination reduces the chance of BV co…
Phase: PHASE2 • Sponsor: Chengdu Syncor Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated May 26, 2026 11:35 UTC